Literature DB >> 23839045

The locus of microRNA-10b: a critical target for breast cancer insurgence and dissemination.

Francesca Biagioni1, Noa Bossel Ben-Moshe, Giulia Fontemaggi, Yosef Yarden, Eytan Domany, Giovanni Blandino.   

Abstract

Contemporary microRNA research has led to significant advances in our understanding of the process of tumorigenesis. MicroRNAs participate in different events of a cancer cell's life, through their ability to target hundreds of putative transcripts involved in almost every cellular function, including cell cycle, apoptosis, and differentiation. The relevance of these small molecules is even more evident in light of the emerging linkage between their expression and both prognosis and clinical outcome of many types of human cancers. This identifies microRNAs as potential therapeutic modifiers of cancer phenotypes. From this perspective, we overview here the miR-10b locus and its involvement in cancer, focusing on its role in the establishment (miR-10b*) and spreading (miR-10b) of breast cancer. We conclude that targeting the locus of microRNA 10b holds great potential for cancer treatment.

Entities:  

Keywords:  cancer; cell proliferation; miR-10b; miR-10b*; microRNA; therapeutic strategies

Mesh:

Substances:

Year:  2013        PMID: 23839045      PMCID: PMC3841316          DOI: 10.4161/cc.25380

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

1.  siRNAs can function as miRNAs.

Authors:  John G Doench; Christian P Petersen; Phillip A Sharp
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs.

Authors:  Rui Yi; Yi Qin; Ian G Macara; Bryan R Cullen
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

4.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

5.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

6.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

7.  Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

Authors:  Gunter Meister; Markus Landthaler; Agnieszka Patkaniowska; Yair Dorsett; Grace Teng; Thomas Tuschl
Journal:  Mol Cell       Date:  2004-07-23       Impact factor: 17.970

8.  Nuclear export of microRNA precursors.

Authors:  Elsebet Lund; Stephan Güttinger; Angelo Calado; James E Dahlberg; Ulrike Kutay
Journal:  Science       Date:  2003-11-20       Impact factor: 47.728

9.  MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.

Authors:  George Adrian Calin; Chang-Gong Liu; Cinzia Sevignani; Manuela Ferracin; Nadia Felli; Calin Dan Dumitru; Masayoshi Shimizu; Amelia Cimmino; Simona Zupo; Mariella Dono; Marie L Dell'Aquila; Hansjuerg Alder; Laura Rassenti; Thomas J Kipps; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-29       Impact factor: 11.205

10.  Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

Authors:  Andrea Bisso; Michela Faleschini; Federico Zampa; Valeria Capaci; Jacopo De Santa; Libero Santarpia; Silvano Piazza; Vera Cappelletti; Mariagrazia Daidone; Reuven Agami; Giannino Del Sal
Journal:  Cell Cycle       Date:  2013-05-01       Impact factor: 4.534

View more
  15 in total

1.  Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b.

Authors:  Rachid El Fatimy; Shruthi Subramanian; Erik J Uhlmann; Anna M Krichevsky
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

Review 2.  The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.

Authors:  Ulrich H Weidle; Steffen Dickopf; Corinna Hintermair; Gwendlyn Kollmorgen; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

3.  What biomarkers (if any) for precise medicine?

Authors:  Sabrina Strano; Paola Muti; Giovanni Blandino
Journal:  Aging (Albany NY)       Date:  2015-08       Impact factor: 5.682

Review 4.  MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.

Authors:  Gloria Bertoli; Claudia Cava; Isabella Castiglioni
Journal:  Theranostics       Date:  2015-07-13       Impact factor: 11.556

5.  Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.

Authors:  Alessandra Mangolini; Manuela Ferracin; Maria Vittoria Zanzi; Elena Saccenti; Sayda Omer Ebnaof; Valentina Vultaggio Poma; Juana M Sanz; Angela Passaro; Massimo Pedriali; Antonio Frassoldati; Patrizia Querzoli; Silvia Sabbioni; Paolo Carcoforo; Alan Hollingsworth; Massimo Negrini
Journal:  Biomark Res       Date:  2015-06-06

6.  Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity.

Authors:  Aristeidis G Telonis; Phillipe Loher; Yi Jing; Eric Londin; Isidore Rigoutsos
Journal:  Nucleic Acids Res       Date:  2015-09-22       Impact factor: 16.971

Review 7.  Novel non invasive diagnostic strategies in bladder cancer.

Authors:  Anamaria Truta; Tudor Adrian Hodor Popon; George Saraci; Liviu Ghervan; Ioan Victor Pop
Journal:  Clujul Med       Date:  2016-04-15

8.  Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.

Authors:  Federica Mori; Maria Ferraiuolo; Raffaela Santoro; Andrea Sacconi; Frauke Goeman; Matteo Pallocca; Claudio Pulito; Etleva Korita; Maurizio Fanciulli; Paola Muti; Giovanni Blandino; Sabrina Strano
Journal:  Oncotarget       Date:  2016-04-12

Review 9.  MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.

Authors:  Manuele Gori; Mario Arciello; Clara Balsano
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

10.  MiRNA-10b sponge: An anti-breast cancer study in vitro.

Authors:  Ai-Ling Liang; Ting-Ting Zhang; Ning Zhou; Cui Yun Wu; Man-Hua Lin; Yong-Jun Liu
Journal:  Oncol Rep       Date:  2016-01-26       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.